Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine

被引:15
作者
Hurben, Alexander K. [1 ]
Erber, Luke N. [1 ,2 ]
Tretyakova, Natalia Y. [1 ,2 ]
Doran, Todd M. [1 ,3 ]
机构
[1] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA
关键词
RAT-BRAIN MITOCHONDRIA; PARKINSONS-DISEASE; OXIDATION-PRODUCTS; ADDUCT FORMATION; QUINONE; IDENTIFICATION; INHIBITION; TYROSINASE; QUINOPROTEIN; NEUROMELANIN;
D O I
10.1021/acschembio.1c00629
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selective death of midbrain dopaminergic neurons is a hallmark pathology of Parkinson's disease (PD), but the molecular mechanisms that initiate the cascade of events resulting in neurodegeneration in PD remain unclear. Compelling evidence suggests that dysregulation of dopamine (DA) induces neuronal stress and damage responses that are operative processes in striatal degeneration preceding PD-like symptoms. Improper DA sequestration to vesicles raises cytosolic DA levels, which is rapidly converted into electrophilic dopaquinone species (DQs) that react readily with protein nucleophiles forming covalent modifications that alter the native structure and function of proteins. These so-called DA-protein adducts (DPAs) have been reported to play a role in neurotoxicity, and their abundance with respect to neurodegeneration has been linked to clinical and pathological features of PD that suggest that they play a causal role in PD pathogenesis. Therefore, characterizing DPAs is a critical first step in understanding the susceptibility of midbrain dopaminergic neurons during PD. To help achieve this goal, we report here a novel DA-mimetic (DA(yne)) containing a biorthogonal alkyne handle that exhibits a reactivity profile similar to DA in aqueous buffers. By linking DPAs formed with DAyne to a fluorescent reporter molecule, DPAs were visualized in fixed cells and within lysates. DA(yne) enabled global mapping of cellular proteins affected by DQ modification and their bioactive pathways through enrichment. Our proteomic profiling of DPAs in neuronal SH-SY5Y cells indicates that proteins susceptible to DPA formation are extant throughout the proteome, potentially influencing several diverse biological pathways involved in PD such as endoplasmic reticulum (ER) stress, cytoskeletal instability, proteotoxicity, and clathrin function. We validated that a protein involved in the ER stress pathway, protein disulfide isomerase 3 (PDIA3), which was enriched in our chemoproteomic analysis, is functionally inhibited by DA, providing evidence that dysregulated cellular DA may induce or exacerbate ER stress. Thus, DAyne provided new mechanistic insights into DA toxicity that may be observed during PD by enabling characterization of DPAs generated reproducibly at physiologically relevant quinone exposures. We anticipate our design and application of this reactivity-based probe will be generally applicable for clarifying mechanisms of metabolic quinone toxicity.
引用
收藏
页码:2581 / 2594
页数:14
相关论文
共 65 条
[1]   INHIBITION OF HUMAN-BRAIN DIHYDROPTERIDINE REDUCTASE [E.C.1.6.99.10] BY THE OXIDATION-PRODUCTS OF CATECHOLAMINES, THE AMINOCHROMES [J].
ARMAREGO, WLF ;
WARING, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 113 (03) :895-899
[2]   Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease [J].
Asanuma, M ;
Miyazaki, I ;
Ogawa, N .
NEUROTOXICITY RESEARCH, 2003, 5 (03) :165-176
[3]   An Alkyne-Aspirin Chemical Reporter for the Detection of Aspirin-Dependent Protein Modification in Living Cells [J].
Bateman, Leslie A. ;
Zaro, Balyn W. ;
Miller, Stephanie M. ;
Pratt, Matthew R. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (39) :14568-14573
[4]   Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease [J].
Belluzzi, Elisa ;
Bisaglia, Marco ;
Lazzarini, Elisabetta ;
Tabares, Leandro C. ;
Beltramini, Mariano ;
Bubacco, Luigi .
PLOS ONE, 2012, 7 (06)
[5]   Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein [J].
Bisaglia, Marco ;
Mammi, Stefano ;
Bubacco, Luigi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (21) :15597-15605
[6]   Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite [J].
Bruning, John M. ;
Wang, Yan ;
Oltrabella, Francesca ;
Tian, Boxue ;
Kholodar, Svetlana A. ;
Liu, Harrison ;
Bhattacharya, Paulomi ;
Guo, Su ;
Holton, James M. ;
Fletterick, Robert J. ;
Jacobson, Matthew P. ;
England, Pamela M. .
CELL CHEMICAL BIOLOGY, 2019, 26 (05) :674-+
[7]   Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease [J].
Burbulla, Lena F. ;
Song, Pingping ;
Mazzulli, Joseph R. ;
Zampese, Enrico ;
Wong, Yvette C. ;
Jeon, Sohee ;
Santos, David P. ;
Blanz, Judith ;
Obermaier, Carolin D. ;
Strojny, Chelsee ;
Savas, Jeffrey N. ;
Kiskinis, Evangelos ;
Zhuang, Xiaoxi ;
Kruger, Rejko ;
Surmeier, D. James ;
Krainc, Dimitri .
SCIENCE, 2017, 357 (6357) :1255-+
[8]   A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci [J].
Chang, Diana ;
Nalls, Mike A. ;
Hallgrimsdottir, Ingileif B. ;
Hunkapiller, Julie ;
van der Brug, Marcel ;
Cai, Fang ;
Kerchner, Geoffrey A. ;
Ayalon, Gai ;
Bingol, Baris ;
Sheng, Morgan ;
Hinds, David ;
Behrens, Timothy W. ;
Singleton, Andrew B. ;
Bhangale, Tushar R. ;
Graham, Robert R. .
NATURE GENETICS, 2017, 49 (10) :1511-+
[9]   Clinical Progression in Parkinson Disease and the Neurobiology of Axons [J].
Cheng, Hsiao-Chun ;
Ulane, Christina M. ;
Burke, Robert E. .
ANNALS OF NEUROLOGY, 2010, 67 (06) :715-725
[10]   Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology [J].
Conn, KJ ;
Gao, WW ;
McKee, A ;
Lan, MS ;
Ullman, MD ;
Eisenhauer, PB ;
Fine, RE ;
Wells, JM .
BRAIN RESEARCH, 2004, 1022 (1-2) :164-172